Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FCYV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,417
Award facts
- Contract value 100% obligated
- $50,416.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $50,416.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count). The award, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, was made without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will fulfill this order under its role as a critical pharmaceutical supplier within the federal supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract, a single-award IDC with a $499.999 billion ceiling value that was established on November 13, 2025, and extends through December 31, 2036. The broader PPV-G GEN V initiative, part of a $30.3 billion acquisition strategy, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to supply a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The contractor's established performance across numerous delivery orders demonstrates its capability to meet the diverse and specialized pharmaceutical requirements of military healthcare facilities.
Quick answers
Who was awarded contract SPE2DR26FCYV6?
SPE2DR26FCYV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FCYV6 worth?
The government has obligated $50,417 on SPE2DR26FCYV6.
Is contract SPE2DR26FCYV6 an order under another contract?
Yes. SPE2DR26FCYV6 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYV6 competed?
The extent of competition for SPE2DR26FCYV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award